Iota-carrageenan and Xylitol inhibit SARS-CoV-2 in cell culture

Iota-carrageenan study #1 of 10 All Outcomes

8/21 In Vitro

Bansal et al., bioRxiv, doi:10.1101/2020.08.19.225854 (Preprint) (In Vitro)
Iota-carrageenan and Xylitol inhibit SARS-CoV-2 in cell culture

Source PDF Share Tweet

In Vitro study showing that iota-carrageenan in concentrations as low as 6 µg/mL (easily achievable with existing nasal sprays) inhibits SARS-CoV-2 in Vero cell cultures.

Bansal et al., 8/21/2020, preprint, 7 authors.

All 10 studies All Outcomes

Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.

Submit